与癌症相关的动脉血栓栓事件
Gilles Pernod1, Ariel Cohen2, Patrick Mismetti3
1Service de Médecine Vasculaire, Université Grenoble-Alpes, Grenoble, France; F-CRIN INNOVTE network, Saint-Etienne, France.
Archives of cardiovascular diseases
|December 6, 2023
概括
癌症患者面临更高的动脉血栓栓塞的风险,如心脏病发作和中风. 这种情况独立地增加了死亡风险,由于出血风险,需要谨慎的抗血栓治疗.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 神经学 神经学
背景情况:
- 癌症与高凝血状态有关,增加了静脉血栓栓塞的风险.
- 癌症和动脉血栓塞栓症之间的关联不太清楚.
- 动脉血栓栓塞 (心肌梗塞,中风) 在癌症患者中更为频繁.
研究的目的:
- 为了研究癌症和动脉血栓塞栓症之间的关联.
- 为了确定患动脉血栓栓塞的风险最高的癌症类型.
- 突出对患者管理和治疗的影响.
主要方法:
- 观察性研究分析了癌症患者的数据.
- 对动脉血栓栓塞事件 (心肌梗塞,中风) 的评估.
- 分析与癌症中的动脉血栓栓塞相关的风险因素和死亡率.
主要成果:
- 动脉血栓栓塞在癌症患者中明显更频繁,独立于血管风险因素.
- 患有动脉血栓栓塞的癌症患者的死亡风险增加了三倍.
- 大脑,肺,结肠直肠和胰腺癌显示动脉血栓栓塞的相对风险最高.
结论:
- 癌症显著增加了动脉血栓栓塞和相关死亡率的风险.
- 特定的癌症类型具有特别高的动脉血栓栓塞的风险.
- 抗血栓治疗需要仔细考虑,因为癌症患者的出血风险增加.
相关概念视频
Disorders of Hemostasis
926
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
926
Anticoagulant Drugs: Low-Molecular-Weight Heparins
711
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
711
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


